Physical counterpressure maneuvers reduced vasovagal syncopePDF
ACP J Club. 2007 Mar-Apr;146:41. doi:10.7326/ACPJC-2007-146-2-041
Clinical Impact Ratings
van Dijk N, Quartieri F, Blanc JJ, et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol. 2006;48:1652-7. [PubMed ID: 17045903]
In patients with vasovagal syncope, does training in physical counterpressure maneuvers reduce recurrent syncope?
Design: Randomized controlled trial (Physical Counterpressure Manoeuvres Trial).
Blinding: Blinded (patients).*
Follow-up period: Mean 14 months.
Setting: 15 medical centers worldwide.
Patients: 223 patients who were 16 to 70 years of age with recurrent vasovagal syncope (≥ 3 syncope episodes in the past 2 y or ≥ 1 syncopal spell and 3 presyncopal episodes in the past y) or a suspected diagnosis confirmed by tilt-table testing who had recognizable prodromal symptoms and a normal physical examination and electrocardiogram. Exclusion criteria included suspected or overt heart disease with a high likelihood of cardiac syncope; orthostatic hypotension; loss of consciousness different from syncope; the vascular steal syndrome; psychological, physical, or cognitive barriers to participation; suspected poor compliance; pregnancy; and life expectancy < 1 year.
Intervention: Conventional therapy (explanation of underlying mechanisms of vasovagal syncope, lifestyle modification advice, and an information leaflet) (n= 117) or conventional therapy plus training in physical counterpressure maneuvers (PCM) (n= 106). PCM consisted of leg crossing with tensing of leg, abdominal, and buttock muscles; handgrip with contraction of a ball or other object; or arm tensing by gripping 1 hand with the other in situations in which patients were prone to vasovagal syncope or when prodromal symptoms occurred.
Outcomes: Burden of syncope recurrence. Secondary endpoint was time to first recurrence.
Patient follow-up: 93% (mean age 38 y, 66% women) (intention-to-treat analysis).
Conventional therapy plus PCM reduced the syncope burden more than did conventional therapy alone (median number of syncope episodes/patient per y 0.0 vs 0.6, P= 0.004). PCM reduced syncope recurrence more than did conventional therapy (Table). Groups did not differ for time to first recurrence (4.8 vs 6.6 mo, P= 0.106). Multivariate analysis showed effectiveness of PCM was not affected by sex, age, previous number of syncopal episodes, results of tilt-table test, or most-used maneuver.
In patients with vasovagal syncope, training in physical counterpressure maneuvers reduced recurrent syncope.
Source of funding: Netherlands Heart Foundation.
For correspondence: Dr. N. van Dijk, Academic Medical Center, Amsterdam, The Netherlands. E-mail email@example.com.
Table. Conventional therapy plus physical counterpressure maneuvers (PCM) vs conventional therapy alone for vasovagal syncope at mean 14 months†
|Outcome||PCM||Conventional therapy||RRR (95% CI)||NNT (CI)|
|Recurrent syncope||32%||51%||36% (11 to 53)||5 (3 to 17)|
†Abbreviations defined in Glossary.
Fainting is most commonly the result of a vasovagal (neurocardiogenic) reflex that causes bradycardia and peripheral vasodilation. Treatments focused on the bradycardia (e.g., pacemakers) have proven ineffective in rigorous studies (1). Treatments designed to counteract the peripheral vasodilation (e.g., high-salt diets, mineralocorticoids, and α-agonists) are potentially harmful, bothersome, unproven, and inefficient (requiring daily intervention for an infrequent event). β-blockers were considered promising because they were thought to block the afferent stimulus for the vasovagal reflex, but they have proven ineffective in placebo-controlled trials (2).
In contrast, van Dijk and colleagues showed that use of specific isometric muscle contractions is a just-in-time intervention that is simple and inexpensive, has a strong biological rationale from experiments in the physiology laboratory, and is clinically effective when taught by different clinicians in multiple clinics.
However, there is a methodological concern. Research on vasovagal syncope provides a superb illustration of the need for rigorous blinding in controlling for the placebo effect. For example, initial trials with pacemakers purported to show dramatic benefit, but these results proved erroneous when additional trials rigorously controlled for the placebo effect by inserting pacemakers in all study participants and randomly (and blindly) keeping half turned off (1). The study by van Dijk was not rigorously blinded because the control-group patients were not taught sham maneuvers; therefore, neither the patients nor the outcome assessors could be truly blinded.
Despite the uncertainty raised by inadequate blinding, the counterpressure maneuvers can be strongly advocated as initial therapy for patients with vasovagal syncope and a prodrome.
Arthur T. Evans, MD, MPH
Cook County Hospital and Rush Medical College
Chicago, Illinois, USA
1. Connolly SJ, Sheldon R, Thorpe KE, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA. 2003;289:2224-9. [PubMed ID: 12734133]
2. Sheldon R, Connolly S, Rose S, et al. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation. 2006;113:1164-70. [PubMed ID: 16505178]